CANF EBITDA Growth
Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · EBITDA Growth
CANF EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-9.26%period ending
CANF TTM EBITDA YoY % (-12.81% → -9.26%)
Year-over-year change
High-resolution chart · PNG
CANF ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -9.2645% | |
| -15.4334% | |
| -22.1963% | |
| -18.6093% | |
| -14.3903% | |
| -13.2444% | |
| 0.6999% | |
| 15.8147% | |
| 23.2084% | |
| 27.879% | |
| 18.8669% | |
| 14.4911% | |
| 15.2737% | |
| 19.9777% | |
| 21.4055% | |
| 10.3091% | |
| -6.2281% | |
| -8.8986% | |
| 8.8043% | |
| 0.7788% | |
| 11.1466% | |
| -2.1432% | |
| -53.948% | |
| -15.2912% | |
| -56.9311% | |
| -87.4365% | |
| -49.1396% | |
| -49.1707% | |
| -4.9905% | |
| 26.3443% | |
| 28.8332% | |
| -15.6275% | |
| -0.0778% | |
| -13.0387% | |
| -23.9153% | |
| -17.0053% | |
| -43.5514% | |
| -42.6325% | |
| -54.7868% | |
| 8.4595% | |
| -11.1158% | |
| -8.2462% | |
| 28.3668% | |
| 26.1086% | |
| 41.5738% | |
| 41.9769% | |
| 24.6664% | |
| -15.7431% | |
| -25.8212% | |
| -38.7941% | |
| -42.0408% | |
| -33.3913% | |
| -32.6397% | |
| -22.1427% | |
| -22.5348% | |
| -12.122% | |
| -12.8105% |